Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FEMY Femasys	$0.73 -5.9%	$0.89	$0.69 ▼ $1.80	$25.26M	-2.58	220,528 shs	326,799 shs
ICAD icad	$3.87	$3.82	$1.19 ▼ $4.02	$106.31M	1.37	426,282 shs	N/A
SLNO Soleno Therapeutics	$83.36 -2.8%	$82.98	$41.50 ▼ $90.32	$4.56B	-2.56	1.19 million shs	991,126 shs
ZJYL Jin Medical International	$0.64 -2.0%	$0.66	$0.50 ▼ $4.08	$101.72M	9.79	264,952 shs	230,435 shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FEMY Femasys	-13.16%	-4.07%	-16.15%	-29.51%	-16.63%
ICAD icad	0.00%	0.00%	+3.48%	-1.53%	+204.72%
SLNO Soleno Therapeutics	+4.14%	+1.95%	+5.14%	+15.21%	+86.80%
ZJYL Jin Medical International	-1.25%	+1.45%	+1.53%	-23.28%	-79.44%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
FEMY Femasys	3.4305 of 5 stars	3.5	5.0	0.0	0.0	2.4	2.5	0.6
ICAD icad	0.5345 of 5 stars	0.0	5.0	0.0	0.0	1.2	0.8	0.0
SLNO Soleno Therapeutics	4.6037 of 5 stars	4.5	1.0	0.0	4.6	3.3	2.5	0.6
ZJYL Jin Medical International	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FEMY Femasys	3.00	Buy	$7.33	904.57% Upside
ICAD icad	2.00	Hold	N/A	N/A
SLNO Soleno Therapeutics	3.09	Buy	$113.30	35.92% Upside
ZJYL Jin Medical International	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest FEMY, SLNO, ICAD, and ZJYL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/11/2025	FEMY Femasys	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$12.00 ➝ $8.00
8/7/2025	SLNO Soleno Therapeutics	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
8/7/2025	SLNO Soleno Therapeutics	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$97.00 ➝ $106.00
8/7/2025	SLNO Soleno Therapeutics	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$105.00 ➝ $110.00
7/11/2025	SLNO Soleno Therapeutics	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Outperform ➝ Outperform	$105.00 ➝ $121.00
6/25/2025	FEMY Femasys	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$12.00
6/23/2025	SLNO Soleno Therapeutics	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy
6/23/2025	SLNO Soleno Therapeutics	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$110.00
6/11/2025	FEMY Femasys	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$12.00
5/13/2025	FEMY Femasys	Jones Trading Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$10.00 ➝ $6.00

(Data available from 8/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FEMY Femasys	$1.63M	14.59	N/A	N/A	$0.05 per share	14.60
ICAD icad	$19.61M	5.42	N/A	N/A	$1.08 per share	3.58
SLNO Soleno Therapeutics	N/A	N/A	N/A	N/A	$4.52 per share	N/A
ZJYL Jin Medical International	$23.50M	4.24	$0.02 per share	25.73	$0.18 per share	3.54

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FEMY Femasys	-$18.82M	-$0.86	N/A	N/A	N/A	-1,113.72%	-713.74%	-152.60%	8/14/2025 (Estimated)
ICAD icad	-$5.62M	-$0.19	N/A	∞	N/A	-26.63%	-15.03%	-11.77%	8/12/2025 (Estimated)
SLNO Soleno Therapeutics	-$175.85M	-$4.14	N/A	N/A	N/A	N/A	-73.74%	-56.67%	N/A
ZJYL Jin Medical International	$3.68M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest FEMY, SLNO, ICAD, and ZJYL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	Q2 2025	ICAD icad	-$0.0550	N/A	N/A	N/A	$4.81 million	N/A
8/8/2025	Q2 2025	FEMY Femasys	-$0.18	-$0.16	+$0.02	-$0.16	$0.80 million	$0.41 million
8/6/2025	Q2 2025	SLNO Soleno Therapeutics	-$0.53	-$0.09	+$0.44	-$0.09	$3.91 million	$32.66 million
5/13/2025	Q1 2025	ICAD icad	-$0.0625	-$0.02	+$0.0425	-$0.03	$4.54 million	$4.87 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
FEMY Femasys	N/A	N/A	N/A	N/A	N/A
ICAD icad	N/A	N/A	N/A	N/A	N/A
SLNO Soleno Therapeutics	N/A	N/A	N/A	N/A	N/A
ZJYL Jin Medical International	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FEMY Femasys	0.03	0.89	0.54
ICAD icad	N/A	3.66	3.57
SLNO Soleno Therapeutics	0.21	15.13	15.01
ZJYL Jin Medical International	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FEMY Femasys	65.27%
ICAD icad	24.61%
SLNO Soleno Therapeutics	97.42%
ZJYL Jin Medical International	N/A

Insider Ownership

Company	Insider Ownership
FEMY Femasys	11.54%
ICAD icad	10.29%
SLNO Soleno Therapeutics	6.40%
ZJYL Jin Medical International	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FEMY Femasys	30	32.58 million	28.77 million	Not Optionable
ICAD icad	140	27.47 million	24.64 million	Optionable
SLNO Soleno Therapeutics	30	53.15 million	49.74 million	Optionable
ZJYL Jin Medical International	245	156.55 million	N/A	Not Optionable

FEMY, SLNO, ICAD, and ZJYL Headlines

Recent News About These Companies

Jin Medical International (NASDAQ:ZJYL) Stock Price Up 0.4% - Time to Buy?

August 2, 2025 | marketbeat.com

Jin Medical International Ltd. Launches Production at New Intelligent Manufacturing Facility in Anhui, China

July 15, 2025 | quiverquant.comQ

Jin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing Facility

July 15, 2025 | globenewswire.com

Jin Medical Faces Nasdaq Listing Compliance Challenge

May 6, 2025 | tipranks.com

Jin Medical International Ltd. -- Nasdaq Minimum Bid Price Non-Compliance

May 6, 2025 | gurufocus.com

Jin Medical International Ltd. – Nasdaq Minimum Bid Price Non-Compliance

May 6, 2025 | globenewswire.com

Is Jin Medical International Ltd.'s (NASDAQ:ZJYL) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

April 28, 2025 | finance.yahoo.com

Jin Medical Boosts Production Capacity with New Chuzhou Facility

April 25, 2025 | tipranks.com

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL)

April 13, 2025 | nasdaq.com

Why Jin Medical International Ltd.’s (ZJYL) Stock Is Down 12.45%

April 3, 2025 | aaii.comA

Why Jin Medical International Ltd.’s (ZJYL) Stock Is Up 10.09%

March 25, 2025 | aaii.comA

Why Jin Medical International Ltd.’s (ZJYL) Stock Is Down 29.03%

March 21, 2025 | aaii.comA

Why Jin Medical International Ltd.’s (ZJYL) Stock Is Up 14.61%

March 20, 2025 | aaii.comA

Why Jin Medical International Ltd.’s (ZJYL) Stock Is Up 11.29%

January 31, 2025 | aaii.comA

Jin Medical International Full Year 2024 Earnings: EPS: US$0.023 (vs US$0.02 in FY 2023)

January 27, 2025 | finance.yahoo.com

Wuhan Jin Jiang International Hotel

November 12, 2024 | travelweekly.comT

Jin of BTS fronts rock band in 'I'll Be There' music video

October 25, 2024 | msn.com

Construction of JinMed's New Facility Begins in Chuzhou, China

October 10, 2024 | globenewswire.com

Some Investors May Be Worried About Jin Medical International's (NASDAQ:ZJYL) Returns On Capital

October 9, 2024 | finance.yahoo.com

ZJYL Sees a Stock Surge of 5.04% Amid Positive Financial Performance

October 2, 2024 | gurufocus.com

Crude Oil Down Over 1%; US Manufacturing PMI Falls In September

September 24, 2024 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

FEMY, SLNO, ICAD, and ZJYL Company Descriptions

Femasys NASDAQ:FEMY

$0.73 -0.05 (-5.86%)

Closing price 04:00 PM Eastern

Extended Trading

$0.78 +0.06 (+7.53%)

As of 07:54 PM Eastern

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

icad NASDAQ:ICAD

$3.87 0.00 (0.00%)

As of 07/17/2025

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

Soleno Therapeutics NASDAQ:SLNO

$83.36 -2.40 (-2.80%)

Closing price 04:00 PM Eastern

Extended Trading

$83.36 0.00 (-0.01%)

As of 04:45 PM Eastern

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

Jin Medical International NASDAQ:ZJYL

$0.64 -0.01 (-2.05%)

Closing price 03:50 PM Eastern

Extended Trading

$0.65 +0.01 (+1.49%)

As of 06:40 PM Eastern

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time